Amneal Pharmaceuticals (AMRX) Tax Provisions (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Tax Provisions of $2.2 million for Q1 2026, down 83.09% year-over-year from $12.9 million in Q1 2025, and down 61.57% quarter-over-quarter from $5.7 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Tax Provisions (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Tax Provisions history runs 10 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 83.09% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $584000.0 (down 97.72% YoY), while the FY2025 annual figure was $11.3 million, down 40.22% from the prior year.
- Tax Provisions for Q1 2026 stood at $2.2 million, down from $5.7 million in the prior quarter.
- The five-year high for Tax Provisions was $16.1 million in Q2 2025, with the low at -$23.4 million in Q3 2025.
- The 5-year median for Tax Provisions is $4.1 million (2022), against an average of $3.0 million.
- The sharpest annual moves came in 2022 and 2024: Tax Provisions sank 965.25% in 2022, then jumped 779.43% in 2024.
- Amneal Pharmaceuticals' Tax Provisions stood at -$1.8 million in 2022, then soared by 637.7% to $9.9 million in 2023, then sank by 45.13% to $5.4 million in 2024, then grew by 4.41% to $5.7 million in 2025, then sank by 61.57% to $2.2 million in 2026.
- Business Quant data shows AMRX's Tax Provisions at $2.2 million in Q1 2026, $5.7 million in Q4 2025, and -$23.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.67 Bn | 5.55 Bn | 334.51 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 5.66 Mn |
| Sep 30, 2025 | -23.36 Mn |
| Jun 30, 2025 | 16.10 Mn |
| Mar 31, 2025 | 12.87 Mn |
| Dec 31, 2024 | 5.42 Mn |
| Sep 30, 2024 | 3.67 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 6.16 Mn |
| Dec 31, 2023 | 9.88 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | -1.84 Mn |
| Sep 30, 2022 | 4.57 Mn |
| Jun 30, 2022 | 7.35 Mn |
| Mar 31, 2022 | -3.46 Mn |
| Dec 31, 2021 | 4.14 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 2.61 Mn |